These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27122276)

  • 21. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
    Douketis JD; Healey JS; Brueckmann M; Eikelboom JW; Ezekowitz MD; Fraessdorf M; Noack H; Oldgren J; Reilly P; Spyropoulos AC; Wallentin L; Connolly SJ
    Thromb Haemost; 2015 Mar; 113(3):625-32. PubMed ID: 25472710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.
    Michaud GF; Pelosi F; Noble MD; Knight BP; Morady F; Strickberger SA
    J Am Coll Cardiol; 2000 Jun; 35(7):1915-8. PubMed ID: 10841243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The BRIDGE trial: What the hospitalist should know.
    Nazha B; Spyropoulos AC
    J Hosp Med; 2016 Sep; 11(9):652-7. PubMed ID: 27098835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac rhythm device surgery with uninterrupted oral anticoagulation.
    Tyagi G; Pai SM; Pai RG
    Future Cardiol; 2013 Nov; 9(6):763-6. PubMed ID: 24180532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
    Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA
    Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry.
    Beyer-Westendorf J; Gelbricht V; Förster K; Ebertz F; Köhler C; Werth S; Kuhlisch E; Stange T; Thieme C; Daschkow K; Weiss N
    Eur Heart J; 2014 Jul; 35(28):1888-96. PubMed ID: 24394381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warfarin anticoagulation in the perioperative period: is it safe?
    Caliendo FJ; Halpern VJ; Marini CP; Nathan IM; Patel D; Faust G; Cohen JR
    Ann Vasc Surg; 1999 Jan; 13(1):11-6. PubMed ID: 9878651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
    Shurrab M; Morillo CA; Schulman S; Kansal N; Danon A; Newman D; Lashevsky I; Healey JS; Crystal E
    Can J Cardiol; 2013 Oct; 29(10):1203-10. PubMed ID: 23993352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.
    Essebag V; AlTurki A; Proietti R; Healey JS; Wells GA; Verma A; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leather R; Ahmad K; Toal S; Sapp J; Sturmer M; Kavanagh K; Crystal E; Leiria TLL; Seifer C; Rinne C; Birnie D;
    Int J Cardiol; 2019 Aug; 288():87-93. PubMed ID: 31056413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].
    Proietti R; Birnie DH; Healey JS; Verma A; Essebag V
    G Ital Cardiol (Rome); 2013 Nov; 14(11):724-5. PubMed ID: 24326634
    [No Abstract]   [Full Text] [Related]  

  • 32. [The BRUISE CONTROL study].
    Landolina ME; Savastano S; Piacenti M
    G Ital Cardiol (Rome); 2013 Nov; 14(11):719-23. PubMed ID: 24326633
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada.
    Krahn AD; Healey JS; Simpson CS; Essebag V; Sivakumaran S; Birnie DH
    Heart Rhythm; 2009 Sep; 6(9):1276-9. PubMed ID: 19716082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question.
    Douketis JD
    Mayo Clin Proc; 2008 Jun; 83(6):628-9. PubMed ID: 18533078
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.
    Kosiuk J; Koutalas E; Doering M; Sommer P; Rolf S; Breithardt OA; Nedios S; Dinov B; Hindricks G; Richter S; Bollmann A
    Europace; 2014 Jul; 16(7):1028-32. PubMed ID: 24489073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis.
    Feng L; Li Y; Li J; Yu B
    Thromb Haemost; 2012 Dec; 108(6):1124-31. PubMed ID: 23051884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.
    Essebag V; Healey JS; Joza J; Nery PB; Kalfon E; Leiria TLL; Verma A; Ayala-Paredes F; Coutu B; Sumner GL; Becker G; Philippon F; Eikelboom J; Sandhu RK; Sapp J; Leather R; Yung D; Thibault B; Simpson CS; Ahmad K; Toal S; Sturmer M; Kavanagh K; Crystal E; Wells GA; Krahn AD; Birnie DH
    Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007545. PubMed ID: 31610718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative management of anticoagulation during device implantation-the UK perspective.
    de Bono J; Nazir S; Ruparelia N; Bashir Y; Betts T; Rajappan K
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):389-93. PubMed ID: 20132500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.